Hanmi Pharm Co Ltd
KRX:128940

Watchlist Manager
Hanmi Pharm Co Ltd Logo
Hanmi Pharm Co Ltd
KRX:128940
Watchlist
Price: 278 000 KRW -1.07% Market Closed
Market Cap: 3.5T KRW
Have any thoughts about
Hanmi Pharm Co Ltd?
Write Note

Hanmi Pharm Co Ltd
Gain/Loss on Disposition of Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hanmi Pharm Co Ltd
Gain/Loss on Disposition of Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gain/Loss on Disposition of Assets CAGR 3Y CAGR 5Y CAGR 10Y
Hanmi Pharm Co Ltd
KRX:128940
Gain/Loss on Disposition of Assets
â‚©1.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Gain/Loss on Disposition of Assets
â‚©3.6B
CAGR 3-Years
N/A
CAGR 5-Years
21%
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Gain/Loss on Disposition of Assets
-â‚©18.7m
CAGR 3-Years
-302%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Gain/Loss on Disposition of Assets
-â‚©1.8m
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Gain/Loss on Disposition of Assets
-â‚©105.6m
CAGR 3-Years
N/A
CAGR 5-Years
37%
CAGR 10-Years
N/A
C
Celltrion Pharm Inc
KOSDAQ:068760
Gain/Loss on Disposition of Assets
â‚©11.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
28%
No Stocks Found

Hanmi Pharm Co Ltd
Glance View

Market Cap
3.5T KRW
Industry
Pharmaceuticals

Hanmi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2010-07-30. The firm operates its business through three segments. The Pharmaceuticals segment manufactures and sells tablets, capsules, injections, syrups, powders and raw materials used in the treatment of hypertension, reflux esophagitis, influenza type A and influenza type B virus infections and hyperlipidemia, among others. The Other segment is engaged in the materials processing. The Export segment produces and sells products such as powders and injections, and exports technologies.

Intrinsic Value
379 659.54 KRW
Undervaluation 27%
Intrinsic Value
Price

See Also

What is Hanmi Pharm Co Ltd's Gain/Loss on Disposition of Assets?
Gain/Loss on Disposition of Assets
1.8B KRW

Based on the financial report for Jun 30, 2024, Hanmi Pharm Co Ltd's Gain/Loss on Disposition of Assets amounts to 1.8B KRW.

What is Hanmi Pharm Co Ltd's Gain/Loss on Disposition of Assets growth rate?
Gain/Loss on Disposition of Assets CAGR 1Y
5 771%

Over the last year, the Gain/Loss on Disposition of Assets growth was 5 771%.

Back to Top